Vaccination for children: NTAGI Covid panel begins talks, may submit recommendations in 15 days
The NEGVEC, which is chaired by Dr V K Paul and co-chaired Union Health Secretary Rajesh Bhushan, will be taking the final decision on the roll-out of Covid-19 vaccination for children in the country. “Once their [NTAGI panel] recommendations are finalised, the NEGVEC will take a decision on their recommendations,” a source said.
Rajesh Bhushan, Union Health Secretary, in a letter stated that in India 7.4 crore children between 15-18 years are eligible for mass vaccination. (File)
Advertisement
THE COVID-19 standing committee of National Technical Advisory Group on Immunization (NTAGI), comprising top scientific experts, has begun discussions on key aspects of a possible roll-out of Covid vaccination for children, The Indian Express has learnt.
Top government sources told The Indian Express that the standing committee of the NTAGI, which comprises experts from premier medical institutions, including AIIMS and ICMR, will be in a position to submit its final recommendation in the next 10-15 days to the high-powered National Expert Group on Vaccine Administration for Covid-19 (NEGVEC).
You have exhausted your monthly limit of free stories.
Read more stories for free with an Express account.
The NEGVEC, which is chaired by Dr V K Paul and co-chaired Union Health Secretary Rajesh Bhushan, will be taking the final decision on the roll-out of Covid-19 vaccination for children in the country. “Once their [NTAGI panel] recommendations are finalised, the NEGVEC will take a decision on their recommendations,” a source said.
Significantly, the scientific discussions related to roll-out of Covid-19 vaccination for children come days after the Indian drug regulator granted emergency use authorisation of Zydus Cadila’s DNA vaccine, which has been approved for children aged above 12.
While the NEGVAC will take a final call on the roll-out, prioritisation and logistics-related vaccination of children, sources said that Zydus Cadila has informed the government that its vaccine will arrive in October and that it aims to produce one crore doses in the first month.
NTAGI is India’s apex advisory body on immunization, which provides guidance to the government on vaccination by undertaking technical reviews of scientific evidence on matters related to immunization policy and programmes.
As the Covid-19 standing committee of the NTAGI has started discussions on vaccination of children, sources said the technical body will be looking at scientific data on co-morbidities among children and the proportion of this vulnerable group to make recommendations to the government on aspects related to prioritisation of vaccination for the children.
Story continues below this ad
Meanwhile, on Wednesday, Health Secretary Bhushan chaired a high-level meeting with all states to review progress of Covid-19 vaccination. The states were advised to focus on enhancing second dose coverage as well as immunization of school teachers and staff.
Ahead of the meeting, Union Health Minister Mansukh Mandaviya announced that more than two crore additional vaccine doses will be sent to the states from August 27 to vaccinate school teachers and non-teaching staff on a priority basis.
“The Union Health Secretary stressed on having a definite district-level plan to increase coverage of second dose. States were advised to undertake targeted strategies like earmarking specific days/ specific vaccination sites/ specific timings every day/ separate queue to exclusively administer second dose of the vaccines,” the Health Ministry said.
“The states were also requested to identify districts whose vaccine coverage is lower than the state average and monitor as well as enhance progress of vaccination in these districts.”
Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies.
With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health.
His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award.
Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time.
Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More